Autogenous fecal peritonitis in wistar rats with permanent bilateral carotid occlusion. Morbidity, mortality and microbiological response

Acta Cirurgica Brasileira

Volumn 28, Issue 4, 2013, Pages 299-306

  Gadelha, Diego Nery Benevides ^a   Melo, Maria Cecília Santos Cavalcanti ^a   Oliveira, Fnamethárcia Kiara Beserra ^b   Brandt, Carlos Teixeira ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

Author keywords

Brain; Carotid arteries; Hypoxia ischemia; Immune system disorders; Microbiology; Peritonitis; Rats

Indexed keywords

ALPHA HEMOLYTIC STREPTOCOCCUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM EXAMINATION; BODY WEIGHT; CAROTID ARTERY LIGATION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IMMUNE RESPONSE; KLEBSIELLA; MALE; MORBIDITY; MORTALITY; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RAT; SEPTICEMIA; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL;

EID: 84876935163     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013000400010     Document Type: Article

References (25)

1. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans.J Am Geriatr Soc. 2012;60(6):1070-7.
2. Weiss G, Steffanie W, Lippert H. Peritonitis: main reason of severe sepsis in surgical intensive care. ZentralblChir. 2007;132(2):130-7.
3. Curcio JD. Antibiotic prescriptions in intensive care units in Latin America. Rev Arg Microbiol. 2011;43:2003-11.
4. Soares MO, Welton NJ, Harrison DA, Peura P, Shankar- Hari M, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM. An evaluation of the feasibility, cost and value of information of a multicentrerandomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess. 2012;16(7):1-186.
5. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013;93(3):329-42.
6. Katayama Y, Terashi A, Sugimoto S, Inamura K, Suzuki S, Sekiguchi F, Akashi A. Experimental cerebral ischemia after bilateral common carotid artery ligation in SHRSP, SHRSR and Wistar rats: correlation between blood pressure and degree of ischemia. No To Shinkei. 1984;36(11):1069-75.
7. Tsuchiya M, Sako K, Yura S, Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res. 1992;89(1):87-92.
8. Aw D, Silva AB, Palmer DB: Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435-46.
9. Ziaja M. Sepsis and septic encephalopathy: characteristics and experimental models. Folia Neuropathol. 2012;50(3):231-9.
10. Ehrnthaller C, Amara U, Weckbach S, Kalbitz M, Huber-Lang M, Bahrami S. Alteration of complement hemolytic activity in different trauma and sepsis models. J Inflamm Res. 2012;5:59-66.
11. Buyne OR, Bleichrodt RP, Verweij PE, Groenewoud HM, van Goor H, Hendriks T. A peritonitis model with low mortality and persisting intra-abdominal abscesses. Int J ExpPathol. 2006;87(5):361-8.
12. Kreimer F, Aguiar JLA, Castro CMMB, Lacerda CM, Reis T, Lisboa Junior F. Respostaterapêutica e inflamatória de ratos com peritonitesecundáriasubmetidosaousotópico de ampicilina/ sulbactam. Acta Cir Bras. 2005;20:31-9.
13. Gonnert FA, Recknagel P, Seidel M, Jbeily N, Dahlke K, Bockmeyer CL, Winning J, Lösche W, Claus RA, Bauer M. Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res. 2011;170:e123-34.
14. Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 1974;10(6):1250-5.
15. Okazaki Y, Matsukawa A. Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Pat Inflamm Allergy Drug Discov. 2009;3(1):26-32.
16. Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524-8.
17. Giacometti A, Silvestri C, Oscar Cirioni O, Bozzi A, Barra D, Ghiselli R, Di Giulio A, Saba V, Mocchegiani F, Scalise G, Luzi C, Orlando F, Mangoni ML, Rinaldi AC. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrobiol Agents Chemother. 2006;50(7): 2478-86.
18. Fieren MW. The local inflammatory responses to infection of the peritoneal cavity in humans: their regulation by cytokines, macrophages, and other leukocytes. Mediators Inflamm. 2012;2012:976241.
19. Gorbach SL, Bartlett JG. Anaerobic infections. 1. N Engl J Med. 1974;290(21):1177-84.
20. Moreno SE, Alves-Filho JC, Alfaya TM, da Silva JS, Ferreira SH, Liew FY. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J Immunol. 2006;177:3218-24.
21. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211:144-56.
22. Bosshart H, Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann N Y Acad Sci. 2007;1096:1-17.
23. Michéa-Hamzehpour M, Auckenthaler R, Regamey P, Pechère JC. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother. 1987;31(11):1803-8.
24. Watanabe R, Matsumoto T, Sano G, Ishii Y, Tateda K, Sumiyama Y,. Uchiyama J, Sakurai S, Matsuzaki S, Imai S, Yamaguchi K. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother. 2007;51:446-52.
25. Busch HJ, Buschmann IR, Mies G, Bode C, Hossmann KA. Arteriogenesis in hypoperfused rat brain. J Cereb Blood Flow Metab. 2003;23(5):621-8